Respiratory

NICE asthma guideline: diagnosis and monitoring

2021-04-20T12:45:00+01:00By NICE

A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms

GOLD COPD 2021 strategy

2021-02-02T09:28:00+00:00By Global Initiative for Chronic Obstructive Lung Disease

A clear summary of GOLD’s 2021 strategy on COPD diagnosis, management, and prevention, including recommendations on COVID-19 and COPD

COVID-19 rapid guideline on cystic fibrosis

2020-10-12T14:26:00+01:00By NICE

The purpose of this Guidelines summary is to maximise the safety of patients with cystic fibrosis and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match capacity to patient needs if services become limited because of the COVID-19 pandemic.

AWMSG asthma guideline

2020-10-08T15:42:00+01:00By All Wales Medicines Strategy Group

Core principles of asthma management, inhaler selection and use, and referral guidance, from the All Wales Medicines Strategy Group

Identifying and managing allergic rhinitis in the asthma population

2020-08-23T04:00:00+01:00By Development Group—Scadding Holmes Ryan and Williams

This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.

View more summaries

Promotional content

ClinOwl - A new resource for healthcare professionals

Promotional material from ClinOwl Ltd

A free resource, which aggregates and curates the latest clinical articles from leading medical journals in a single view. Keep up to date quickly and easily. You will be redirected to ClinOwl.com.

Educational resources

The re-usable Respimat® Soft Mist inhaler

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines.
View prescribing information
PC-GB-103141 November 2020